E-cigarettes increase risk of cigarette smoking in youth

June 28, 2017

Electronic (e)-cigarette use has risen rapidly among adolescents and young adults since the product was introduced to the U.S. in 2007 and now exceeds the rate of cigarette smoking in this segment of the population. E-cigarettes may harm public health and ultimately increase the burden of cancer if their use contributes to more cigarette smoking among youth. A new collaborative Dartmouth study led by Samir, Soneji, MA, PhD, and James Sargent, MD, demonstrates that this potential harm of e-cigarettes should be taken very seriously.

The study focused on an important and controversial question: Does e-cigarette use increase the risk of future cigarette smoking among adolescents and young adults? The team conducted a systematic review and meta-analysis of published studies that began with nonsmoking youths and asked whether initial e-cigarettes use increased the risk they would subsequently transition to smoking cigarettes. To rule out the possibility that e-cigarette users were simply higher risk youths, the analyses adjusted for known risk factors for cigarette smoking (like having a friend that smokes). The results showed strong and consistent evidence of greater risk between initial e-cigarette use and subsequent cigarette smoking initiation, regardless of how initiation was defined and net other factors that predict cigarette smoking. Their findings, "E-Cigarette Use and Subsequent Cigarette Smoking Among Adolescents and Young Adults: A Systematic Review and Meta-Analysis" will be published in an upcoming issue of JAMA Pediatrics.

The studies did not address why e-cigarette use increases risk of transitioning to cigarettes. The reason could be that e-cigarettes mimic smoking behavior through similar involvement of hand-to-mouth movements, or puffing and exhalation. E-cigarette aerosol also contains nicotine, so use of these devices could enhance exposure and eventual addiction to this substance.

"The finding is very consistent across studies. That along with the strength of the association makes it probable that e-cigarette use is one cause of cigarette smoking," said James Sargent. "E-cigarette use could affect population trends in youth smoking if use becomes more common, and that is the big public health concern."

"In addition to the currently enacted age restrictions on in-store sales, regulatory actions to limit e-cigarette use could include restrictions on advertising campaigns that may be viewed by adolescents, flavor restrictions for e-cigarettes that exclude fruit and candy flavors, strict standards for reporting actual nicotine content in e-liquid, and requirements for strict age verification for online and retail sales of these products" suggests Soneji. Until more effective regulatory actions are taken, the team will continue to evaluate the excess risk posed by e-cigarette use for cigarette smoking with newer generations of e-cigarettes.
Samir Soneji, MA, PhD, is an Assistant Professor of The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth and member of the Cancer Control Research Program at Dartmouth-Hitchcock Norris Cotton Cancer Center. James Sargent, MD, is a Professor of Pediatrics, Biomedical Data Science, Community and Family Medicine and Pediatric Oncology at Dartmouth's Geisel School of Medicine, co-Director of the Cancer Control Research Program at Dartmouth-Hitchcock Norris Cotton Cancer Center and Director of the C. Everett Koop Institute at Dartmouth.

This work was funded by the National Cancer Institute, the Food and Drug Administration, the Center for Tobacco Products and the National Institute on Drug Abuse at the National Institutes of Health.

About Norris Cotton Cancer Center at Dartmouth-Hitchcock

Norris Cotton Cancer Center combines advanced cancer research at Dartmouth's Geisel School of Medicine with patient-centered cancer care provided at Dartmouth-Hitchcock Medical Center in Lebanon, NH, at Dartmouth-Hitchcock regional locations in Manchester, Nashua and Keene, NH, and St. Johnsbury, VT, and at partner hospitals throughout New Hampshire and Vermont. It is one of 45 centers nationwide to earn the National Cancer Institute's "Comprehensive Cancer Center" designation. Learn more about Norris Cotton Cancer Center research, programs, and clinical trials online at cancer.dartmouth.edu.

Dartmouth-Hitchcock Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.